{"id":"https://openalex.org/W1996272015","doi":"https://doi.org/10.1002/phar.1311","title":"Association of Antidepressant and Atypical Antipsychotic Use with Cardiovascular Events and Mortality in a Veteran Population","display_name":"Association of Antidepressant and Atypical Antipsychotic Use with Cardiovascular Events and Mortality in a Veteran Population","publication_year":2013,"publication_date":"2013-06-17","ids":{"openalex":"https://openalex.org/W1996272015","doi":"https://doi.org/10.1002/phar.1311","mag":"1996272015","pmid":"https://pubmed.ncbi.nlm.nih.gov/23776095"},"language":"en","primary_location":{"id":"doi:10.1002/phar.1311","doi":"https://doi.org/10.1002/phar.1311","is_oa":false,"landing_page_url":"https://doi.org/10.1002/phar.1311","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024739928","display_name":"Tushar Acharya","orcid":"https://orcid.org/0000-0001-7315-8368","observed_orcids":["https://orcid.org/0000-0001-7315-8368"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210147977","display_name":"VA Central California Health Care System","ror":"https://ror.org/03wjr6873","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210125474","https://openalex.org/I4210147977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tushar Acharya","raw_affiliation_strings":["Department of Medicine, University of California, San Francisco, Fresno Medical Education Program, Fresno, California","Primary Care Service, Veterans Administration Central California Health Care System, Fresno, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of California, San Francisco, Fresno Medical Education Program, Fresno, California","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Primary Care Service, Veterans Administration Central California Health Care System, Fresno, California","institution_ids":["https://openalex.org/I4210147977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060371022","display_name":"Sabeena Acharya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sabeena Acharya","raw_affiliation_strings":["Department of Psychiatry, University of California, San Francisco, Fresno Medical Education Program, Fresno, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of California, San Francisco, Fresno Medical Education Program, Fresno, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054789730","display_name":"Steven Tringali","orcid":"https://orcid.org/0000-0001-5999-0027","observed_orcids":["https://orcid.org/0000-0001-5999-0027"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210147977","display_name":"VA Central California Health Care System","ror":"https://ror.org/03wjr6873","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210125474","https://openalex.org/I4210147977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Tringali","raw_affiliation_strings":["Department of Medicine, University of California, San Francisco, Fresno Medical Education Program, Fresno, California","Primary Care Service, Veterans Administration Central California Health Care System, Fresno, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of California, San Francisco, Fresno Medical Education Program, Fresno, California","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Primary Care Service, Veterans Administration Central California Health Care System, Fresno, California","institution_ids":["https://openalex.org/I4210147977"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105405180","display_name":"Jian Huang","orcid":"https://orcid.org/0000-0002-7084-8926","observed_orcids":["https://orcid.org/0000-0002-7084-8926"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210147977","display_name":"VA Central California Health Care System","ror":"https://ror.org/03wjr6873","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210125474","https://openalex.org/I4210147977"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jian Huang","raw_affiliation_strings":["Department of Medicine, University of California, San Francisco, Fresno Medical Education Program, Fresno, California","Primary Care Service, Veterans Administration Central California Health Care System, Fresno, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of California, San Francisco, Fresno Medical Education Program, Fresno, California","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Primary Care Service, Veterans Administration Central California Health Care System, Fresno, California","institution_ids":["https://openalex.org/I4210147977"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5105405180"],"corresponding_institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210147977"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":1.6808,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.84800045,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"33","issue":"10","first_page":"1053","last_page":"1061"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11083","display_name":"Cardiac Health and Mental Health","score":0.6977999806404114,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11083","display_name":"Cardiac Health and Mental Health","score":0.6977999806404114,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.27730000019073486,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.8920000195503235},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9990000128746033},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.9010000228881836},{"id":"https://openalex.org/keywords/veterans","display_name":"veterans","score":0.9190000295639038},{"id":"https://openalex.org/keywords/cardiovascular-events","display_name":"cardiovascular events","score":0.9850000143051147},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.9760000109672546},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.8529999852180481},{"id":"https://openalex.org/keywords/cerebrovascular-events","display_name":"cerebrovascular events","score":0.9779999852180481},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9150000214576721},{"id":"https://openalex.org/keywords/mirtazapine","display_name":"mirtazapine","score":0.8650000095367432},{"id":"https://openalex.org/keywords/trazodone","display_name":"trazodone","score":0.8209999799728394},{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":0.9769999980926514},{"id":"https://openalex.org/keywords/concomitant-drug-use","display_name":"concomitant drug use","score":0.703000009059906},{"id":"https://openalex.org/keywords/smoking","display_name":"smoking","score":0.4259999990463257},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.6079999804496765},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.6349999904632568}],"concepts":[{"id":"https://openalex.org/C2781068410","wikidata":"https://www.wikidata.org/wiki/Q421930","display_name":"Mirtazapine","level":4,"score":0.7561636567115784},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7167596220970154},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6399452686309814},{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.6338831186294556},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.6156160831451416},{"id":"https://openalex.org/C2780980600","wikidata":"https://www.wikidata.org/wiki/Q411457","display_name":"Trazodone","level":4,"score":0.5955410003662109},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.5080606937408447},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.47265589237213135},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4575161337852478},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.43859216570854187},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.4141637682914734},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.32803481817245483},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.1995944082736969},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000078785","descriptor_name":"Mirtazapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014728","descriptor_name":"Veterans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/phar.1311","doi":"https://doi.org/10.1002/phar.1311","is_oa":false,"landing_page_url":"https://doi.org/10.1002/phar.1311","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},{"id":"pmid:23776095","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23776095","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W176364038","https://openalex.org/W1625797753","https://openalex.org/W1968936757","https://openalex.org/W1971031023","https://openalex.org/W1988646408","https://openalex.org/W2009127468","https://openalex.org/W2024993254","https://openalex.org/W2026962900","https://openalex.org/W2035732555","https://openalex.org/W2036891077","https://openalex.org/W2037660577","https://openalex.org/W2039152977","https://openalex.org/W2055421991","https://openalex.org/W2057242026","https://openalex.org/W2072379598","https://openalex.org/W2074335684","https://openalex.org/W2075310117","https://openalex.org/W2082486375","https://openalex.org/W2097633023","https://openalex.org/W2099827319","https://openalex.org/W2103447016","https://openalex.org/W2106239116","https://openalex.org/W2111174097","https://openalex.org/W2113929941","https://openalex.org/W2125434307","https://openalex.org/W2126795224","https://openalex.org/W2130717716","https://openalex.org/W2131690429","https://openalex.org/W2131808622","https://openalex.org/W2135310457","https://openalex.org/W2139560403","https://openalex.org/W2141979001","https://openalex.org/W2151352724","https://openalex.org/W2151499150","https://openalex.org/W2158245987","https://openalex.org/W2168362160","https://openalex.org/W2171956687","https://openalex.org/W4250912862"],"related_works":["https://openalex.org/W2158777428","https://openalex.org/W4315574143","https://openalex.org/W2115053421","https://openalex.org/W4399069513","https://openalex.org/W2069537050","https://openalex.org/W4410107498","https://openalex.org/W2953883145","https://openalex.org/W2199554510","https://openalex.org/W7096439910","https://openalex.org/W2755406504"],"abstract_inverted_index":{"STUDY":[0],"OBJECTIVES:":[1],"To":[2],"determine":[3,20],"the":[4,33,106,109,176,285,302],"patterns":[5],"of":[6,35,57,169,230,240,250,273,289,292],"antidepressant":[7,27,66,72,151,157,221],"and":[8,18,29,32,38,80,95,119,145,182,195,218,259,312],"atypical":[9,30,170,241],"antipsychotic":[10],"use":[11,168,198,223,306],"in":[12,301,307],"a":[13,50,247],"veteran":[14],"population":[15],"with":[16,61,175,202,227,246,275,299,309],"depression,":[17],"to":[19,156,284],"if":[21],"an":[22],"association":[23],"exists":[24],"between":[25,77],"specific":[26,219],"classes":[28,187],"antipsychotics":[31,171,242,295],"occurrence":[34],"cardiovascular":[36,281],"events":[37,252],"all-cause":[39,204,260],"mortality.":[40],"DESIGN:":[41],"Retrospective,":[42],"cross-sectional":[43],"study.":[44],"SETTING:":[45],"Primary":[46],"care":[47],"clinic":[48],"at":[49,279],"Veterans":[51],"Affairs":[52],"hospital.":[53],"PATIENTS:":[54],"A":[55],"total":[56],"1136":[58,107],"patients":[59,75,278,308],"diagnosed":[60],"depression":[62,274,313],"who":[63],"were":[64,99,117,121,153,164],"receiving":[65,150],"monotherapy":[67,152],"(664":[68],"patients)":[69],"or":[70],"no":[71],"therapy":[73,97],"(472":[74],"[controls])":[76],"June":[78],"2009":[79],"December":[81],"2010.":[82],"MEASUREMENTS":[83],"AND":[84],"MAIN":[85],"RESULTS:":[86],"Data":[87],"on":[88],"patient":[89,111],"demographics,":[90,192],"disease":[91],"diagnoses,":[92],"laboratory":[93],"data,":[94],"drug":[96],"profiles":[98],"collected":[100],"through":[101],"medical":[102],"record":[103],"review.":[104],"Of":[105],"patients,":[108],"mean":[110],"age":[112],"was":[113,127,172,199,224,243],"61":[114],"years,":[115],"90%":[116],"men,":[118],"77%":[120],"smokers.":[122],"Mean":[123],"body":[124],"mass":[125],"index":[126],"30.4":[128],"kg/m(2)":[129],",":[130],"blood":[131],"pressure":[132],"126/73":[133],"mm":[134],"Hg,":[135],"hemoglobin":[136],"A1c":[137],"6%,":[138],"low-density":[139],"lipoprotein":[140],"cholesterol":[141],"level":[142],"106.7":[143],"mg/dl,":[144],"Framingham":[146],"score":[147],"17.":[148],"Patients":[149],"grouped":[154],"according":[155],"class;":[158],"selective":[159],"serotonin":[160,183],"reuptake":[161,178],"inhibitors":[162],"(SSRIs)":[163],"most":[165],"common.":[166],"Concomitant":[167],"more":[173],"common":[174],"serotonin-norepinephrine":[177],"inhibitor":[179],"(venlafaxine),":[180],"SSRI,":[181],"receptor":[184],"antagonist":[185],"(trazodone)":[186],"(p=0.0067).":[188],"After":[189],"adjusting":[190],"for":[191],"concomitant":[193],"drugs,":[194],"comorbidities,":[196],"SSRI":[197],"significantly":[200,225,244],"associated":[201,226,245],"lower":[203],"mortality":[205,261,287],"(odds":[206],"ratio":[207],"[OR]":[208],"0.37,":[209],"95%":[210,235,255,264],"confidence":[211],"interval":[212],"[CI]":[213],"0.19-0.71,":[214],"p=0.0028).":[215],"Notably,":[216],"noradrenergic":[217],"serotonergic":[220],"(mirtazapine)":[222],"higher":[228,248],"prevalence":[229,249],"heart":[231,310],"failure":[232,311],"(OR":[233,253,262],"3.26,":[234],"CI":[236,256,265],"1.029-10.38,":[237],"p=0.0445).":[238],"Use":[239],"cerebrovascular":[251],"2.23,":[254],"1.29-3.83,":[257],"p=0.0036)":[258],"2.05,":[263],"1.03-4.1,":[266],"p=0.04).":[267],"CONCLUSION:":[268],"Our":[269],"results":[270],"favor":[271],"treatment":[272],"SSRIs":[276],"among":[277],"increased":[280],"risk":[282],"due":[283],"potential":[286],"benefit":[288],"this":[290],"class":[291],"drugs.":[293],"Atypical":[294],"should":[296],"be":[297],"used":[298],"caution":[300],"elderly":[303],"population.":[304],"Mirtazapine":[305],"deserves":[314],"further":[315],"investigation.":[316]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}